LUMKIBI

Welcome to the Brand page for “LUMKIBI”, which is offered here for The mark consists of the stylized word lumkibi.;pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease;color is not claimed as a feature of the mark.;the wording lumkibi has no meaning in a foreign language.;.

Its status is currently believed to be active. Its class is unavailable. “LUMKIBI” is believed to be currently owned by “DAIICHI SANKYO COMPANY, LIMITED”.

Owner:
DAIICHI SANKYO COMPANY, LIMITED
Owner Details
Description:
The mark consists of the stylized word LUMKIBI.;Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease;Color is not claimed as a feature of the mark.;The wording LUMKIBI has no meaning in a foreign language.;
Categories: